Benchling | LiMSforum.com - The Global Laboratory, Informatics, Medical and Science Professional Community

The Future of Food Starts with Modern Life Science Software

Benchling — Tue, 16 Mar 2021 14:11:50 +0000

The science of culturing food has made incredible strides in the last few decades. Behind this innovative push to rethink the way we grow our food, scientific teams depend on scientific technologies, like strain engineering and fermentation, that are...

[Read More]

Benchling for Education: How software is preparing the next generation of scientists

Benchling — Tue, 09 Mar 2021 14:24:53 +0000

During a time of unprecedented changes to education across the globe, we’re proud to announce our newest initiative, Benchling for Education. As schools and universities continue to adopt remote teaching methods, the tools educators use for their...

[Read More]

From the Bench to Benchling

Benchling — Tue, 03 Nov 2020 14:57:34 +0000

Benchling is a next-gen laboratory informatics platform that is helping life science companies manage increasingly complex data workflows. GEN Edge talks to CEO/co-founder Saji Wickramasekara and Michael Schwartz, Head of Product Marketing. [Read More]

Running A Life Science R&D Business with Dr. Aaron Sato, CSO of Twist Biopharma

Benchling — Tue, 06 Oct 2020 15:26:19 +0000

This is the second article in a three-part series of Q&A conversations with Dr. Aaron Sato, CSO of Twist Biopharma, a division of Twist Bioscience. Part one focused on how Twist is adapting to the ongoing COVID-19 crisis and appeared in the spring edition of Benchtalk Journal. Part three will focus on Dr. Sato’s career as well as the unique approach Twist Biopharma is taking to antibody discovery and will appear in the fall edition of Benchtalk Journal.

[Read More]

SARS-CoV-2 and the Human Body: New Evidence of How Our Immune System Fights Back

Benchling — Tue, 29 Sep 2020 15:32:00 +0000

Coronaviruses are a group of enveloped, positive-sense strand RNA viruses that are characterized by their “corona,” or crown, of spike-like structures. Some coronaviruses, like 229E and HKU1, are common among humans and can cause mild upper respiratory illness. The latest emerging human coronavirus, SARS-CoV-2, is not to be mistaken with its common cold cousins. It is capable of causing severe illness, damaging a wide range of bodily systems, and its wake has left the world in disarray.

[Read More]

Benchling Case Study Anthology: Pushing the Frontier of Life Science Innovation

Benchling — Wed, 29 Jul 2020 14:43:55 +0000

From next-generation cell therapies, to CRISPR-based gene therapies, to biologically-derived materials, life science R&D has never been more complex or more varied. But despite the explosion in scientific techniques and applications, modern life science companies have one challenge in common: taming the complexity of their data. Paper notebooks, spreadsheets, and legacy software like ELNs and LIMS can’t handle the complexity of modern life science.

[Read More]

Benchling Raises $50M to Accelerate Life Science R&D Globally

Benchling — Tue, 02 Jun 2020 15:28:00 +0000

Benchling is announcing a $50M Series D investment, led by Alkeon Capital with participation from new investors Spark Capital, Lux Capital, and ICONIQ Partners, as well as existing investors Thrive Capital, Menlo Ventures, and Benchmark. We are thrilled to have these long-term partners on our journey. The ongoing pandemic has put biotechnology under the global spotlight. As scientists race to develop treatments and vaccines for COVID-19 on an unprecedented timescale, we’re seeing how far life science has come.

[Read More]

Benchling Insights: Intelligence to power your R&D

Benchling — Tue, 12 May 2020 14:51:18 +0000

We are thrilled to announce Benchling Insights, a new solution for life science R&D companies to make faster, more informed decisions from their data. Insights is seamlessly integrated with all Benchling applications, and enables users to query, visualize, and collaborate around high quality, structured data that resides on the platform. Benchling enables the creation of higher quality data through a unified data model. Now, with Insights, our customers have the tools to make faster, more informed decisions about their scientific pipeline and operational processes, ultimately accelerating the pace of their research. Best of all, this product is automatically included in subscriptions to the Benchling Professional and Benchling Enterprise editions.

Benchling Launches Integrated Analytics Solution to Accelerate Life Science R&D

Benchling — Tue, 05 May 2020 14:57:40 +0000

Benchling, the leading life sciences R&D cloud, today announced the launch of Benchling Insights, a new solution that gives life sciences companies the ability to query, visualize and collaborate around high quality, structured data that resides on the platform. Benchling Insights delivers a 360-degree view of scientific programs and operations to drive faster, more informed decision-making.

Away From the Bench During COVID-19: A Conversation with Dr. Colles Price

Benchling — Tue, 28 Apr 2020 17:27:00 +0000

Colles Price, M.S., PhD is a Research Fellow in Medicine at Dana Farber Cancer Institute, Harvard Medical School, and a Postdoctoral Scholar, Cancer Program, Broad Institute. He is currently identifying and validating targets from the Cancer Dependency Map. In particular, he is interested in understanding the anti-cancer effects of hypoxia-related genes and how polar-related genes control cell proliferation and viability. We had the chance to sit down with him and learn about how COVID-19 is affecting his research.

How Biotech Labs are Adjusting to the COVID-19 Era

Benchling — Tue, 28 Apr 2020 17:22:17 +0000

As an industry that relies on having employees in the lab, biotech has been disrupted by COVID-19 and the dramatic and unexpected set of changes it has introduced. For many scientists, working remotely is a brand new concept. And yet, the scientific industry is also being called upon to develop tests, therapies, and vaccines that put this crisis to rest. To share how biotechs around the world are managing their projects, caring for their people, and supporting the community during coronavirus, we built a guide with best practices and unique ideas from our customers.

How biotechs are racing to develop COVID-19 treatments – Part 2 of 3

Benchling — Tue, 14 Apr 2020 13:45:45 +0000

The novel coronavirus has had sweeping effects on the world at large since its emergence last winter, and it will no doubt continue to affect and change the world we live in. As we do our part to shelter-in-place and practice social distancing, there are leagues of scientists and researchers working around the clock on therapeutics to treat patients infected with SARS-CoV 2. This article is the second in a three-part series covering the response of biotech companies to the COVID-19 crisis. The first article in this series is: How biotechs are racing to develop COVID-19 tests.

How biotechs are racing to develop COVID-19 tests – Part 1 of 3

Benchling — Tue, 14 Apr 2020 13:27:42 +0000

How biotechs are racing to develop COVID-19 tests

Benchling — Tue, 31 Mar 2020 18:56:06 +0000

The novel SARS-CoV-2 virus and the disease it causes (COVID-19) are sweeping the world. The US’s ability to rapidly and accurately test patients, not to mention their health care providers, is critical to containing the virus. That said, it has proved to be one of the biggest challenges for our country in recent weeks. Much has already been written about what initially went wrong with the coronavirus testing in the US and why the US government and CDC lagged behind other developed nations in deploying diagnostics. This article will instead focus on the remarkable companies, institutions, and clinical labs that are rising to the challenge by working around the clock to produce high volumes of accurate and reliable tests. In addition to the COVID-19 tests that are already in use, companies are prototyping groundbreaking new diagnostics. These new tests have the potential to revolutionize COVID-19 detection now and chart the course for the future of infectious disease diagnostics.

[Read More]

A place to share COVID-19 resources with the scientific community

Benchling — Tue, 31 Mar 2020 18:32:01 +0000

In the midst of the COVID-19 outbreak, the world is looking to the scientific community for help. We know that scientists everywhere are mobilizing to characterize the virus, to replicate and study it in lab, to perform testing and analyze results, to develop next-gen diagnostics, and to quickly develop vaccines and antiviral treatments. To support these efforts, we have set up a COVID-19 resources webpage that points to sequences, protocols, and other work that has been shared by scientists for public use. Our hope is that these resources will be beneficial to the greater scientific community, especially to scientists who are actively addressing this challenge. We are accepting submissions from scientists and will be updating the page regularly. You may share data in Benchling — protocols, sequences, experimental results. You may also share an existing resource with us — a pre-print, a published protocol. Please find instructions for contributing below.

[Read More]

A Conversation with Dr. Nigel Mouncey, Director of the Joint Genome Institute: The next frontier of genomic breakthroughs

Benchling — Mon, 23 Mar 2020 15:05:50 +0000

Nigel Mouncey, PhD is the Director of the Joint Genome Institute (JGI), a U.S. Department of Energy Office of Science National User Facility located at Lawrence Berkeley National Laboratory in Berkeley, California. Previously, Dr. Mouncey held increasing leadership roles at Dow AgroSciences, most recently as the Director of R&D for Bioengineering and Bioprocessing. Before that, he led research groups at DSM Nutritional Products and Roche Vitamins. We sat down with Dr. Mouncey to discuss the most exciting ongoing developments in genomic research and how data will continue to shape life science R&D.

[Read More]

Generating FAIR — Findable, Accessible, Interoperable, Reusable — Resources with Marchantia, a Prototype for Plant Synthetic Biology

Benchling — Mon, 23 Mar 2020 15:02:12 +0000

“Classic!” That’s a veteran lab member’s response when a new PhD student recognizes that a plasmid doesn’t have the expected sequence. I have personally heard this, and I have seen it happening around me many more times. DNA constructs from other labs, or even from former members of your own lab, can often be poorly documented. As a result, scientists waste time and resources by having to recheck or redo previous work. And that’s just the tip of the iceberg when it comes to data management challenges in a highly dynamic and resource-limited academic environment. In this environment, working practices and structural constraints have tended to prioritize innovation before documentation. Fortunately, this has been changing for some time, as data-driven biology and society have demanded well-characterized research and open science in order to make research more reproducible and more transparent.

[Read More]

SynBioBeta | Benching & Pairwise – The Future of Agriculture

Benchling — Tue, 17 Mar 2020 18:01:22 +0000

Through SynBioBeta's webinar series, Benchling and Pairwise came together to discuss how gene editing allows the production of new and improved crops that are more sustainable, more nutritious, and more affordable. We also covered the challenges and opportunities for using gene editing to bring better food to market. Watch Now:

Forbes Names Benchling One of America’s Best Startup Employers March 10, 2020 Forbes

Benchling — Tue, 17 Mar 2020 17:41:46 +0000

Benchling has been named as one of America's Best Startup Employers by Forbes. Forbes partnered with market research company Statista to identify the up-and-coming companies liked best by their employees in our inaugural ranking of America’s best startup employers. The list was compiled by evaluating 2,500 American businesses with at least 50 employees on three criteria: employer reputation, employee satisfaction and growth.

[Read More]

(Forbes.com link)

Benchling for Lab Automation: Harness the full potential of your lab hardware

Benchling — Tue, 10 Mar 2020 15:05:28 +0000

Benchling for Lab Automation is a new addition to the Benchling platform that gives life science R&D teams a centralized environment to design, document, run, and analyze up to 10,000 samples at once. Working seamlessly with liquid handling hardware and analytical instrumentation, Benchling helps life science companies maximize output from their automation investments and accelerate the path to discovery.